Azam Majidi - Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran
Reza Ghiasvand - Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran
Maryam Hadji - Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran
Azin Nahvijou - Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran
Azam-Sadat Mousavi - Department of Genecology Oncology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Minoo Pakgohar - Department of Reproductive Health, School of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran
Nahid Khodakarami - Cancer Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran
Mehrandokht Abedini - Deputy of Public Health, Maternal Office, Ministry of Health and Medical Education, Tehran, Iran
Farnaz Amouzegar Hashemi - Radiotherapy Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran
Marjan Rahnamaye Farzami - Central Reference Laboratory, Ministry of Health and Medical Education, Tehran, Iran
Reza Shahsiah - Department of Pathology, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran
Sima Sajedinejhad - Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Mohammad Ali Mohagheghi - Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran
Fatemeh Nadali - Faculty of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran
Arash Rashidian - Department of Health Management and Economics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran
Elisabete Weiderpass - Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Ole Mogensen - Department of Gynecology and Obstetrics, Odense University Hospital, Odense, Denmark
Kazem Zendehdel - Cancer Research Center, Cancer Institute of Iran, Tehran University of Medical Sciences, Tehran, Iran

Background Cervical cancer is the fourth most common cancer among women worldwide. Organized cervical screening and vaccination against human papilloma virus (HPV) have been successful interventions for prevention of invasive cervical cancer (ICC). Because of cultural and religious considerations, ICC has low incidence in Iran and many other Muslim countries. There is no organized cervical screening in these countries. Therefore, ICC is usually diagnosed in advanced stages with poor prognosis in these countries. We performed a priority setting exercise and suggested priorities for prevention of ICC in this setting.   Methods We invited experts and researchers to a workshop and asked them to list important suggestions for ICC prevention in Iran. After merging similar items and removing the duplicates, we asked the experts to rank the list of suggested items. We used a strategy grid and Go-zone analysis to determine final list of priorities for ICC prevention in Iran.   Results From ۲۶ final items suggested as priorities for prevention of ICC, the most important priorities were developing national guidelines for cervical screening and quality control protocol for patient follow-up and management of precancerous lesions. In addition, we emphasized considering insurance coverage for cervical screening, public awareness, and research priorities, and establishment of a cervical screening registry.   Conclusion A comprehensive approach and implementation of organized cervical screening program is necessary for prevention of ICC in Iran and other low incidence Muslim countries. Because of high cost for vaccination and low incidence of cervical cancer, we do not recommend HPV vaccination for the time being in Iran.

Invasive Cervical Cancer (ICC), Priority Setting, Screening, Prevention and Control, Iran